0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover305.44%IV58.56%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.4175Delta0.1069Gamma6.31Leverage Ratio-0.0307Theta0.0008Rho2.63Eff Leverage0.0047Vega
TELA Bio Stock Discussion
NEWS
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
TELA Bio, Inc. announces the U.S. commercial launch of OviTex IHR, a reinforced tissue matrix for inguinal hernia repair. The product offers trocar-compatibility for laparoscopic and robotic procedures, with three configurations available. OviTex has a strong clinical track record with low recurrence rates and high pati...
Beat revenue estimates and near miss on GAAP.
FDA approved surgical device
Buy this asap
No comment yet